Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Nizatidine: a meta-analytical study]

V di Ciommo1, F Ferrario

  • 1Ospedale Bambino Gesù di Palidoro (RM), Servizio di Medicina.

La Clinica Terapeutica
|September 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Extended nodal radiotherapy for prostate cancer relapse guided with [11C]-choline PET/CT: ten-year results in patients enrolled in a prospective trial.

European journal of nuclear medicine and molecular imaging·2023
Same author

Management of obstructive pathology of the salivary glands in elderly patients: a preliminary study.

The Journal of laryngology and otology·2021
Same author

Glial choristoma of the ventral part of the tongue: first report in an elderly patient.

Pathologica·2017
Same author

Children who develop type 1 diabetes early in life show low levels of carnitine and amino acids at birth: does this finding shed light on the etiopathogenesis of the disease?

Nutrition & diabetes·2013
Same author

Role of biopsy in low-grade laryngeal chondrosarcoma: report of two cases.

Pathologica·2013
Same author

2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides.

Arthritis and rheumatism·2012
Same journal

Effectiveness of Focal Muscle Vibration in Post-Anterior Cruciate Ligament Reconstruction Rehabilitation: A Case Report.

La Clinica terapeutica·2026
Same journal

Violence Against Women as a Public-Health Exposure: Biological Embedding, Medico-Legal Caution and Precision Prevention in the EpiWe Framework.

La Clinica terapeutica·2026
Same journal

Suicide of the Work-Disabled Individual Affected by Neoplasia with Unfavorable Prognosis: Evidence-Based Legal Medicine in Reconstructing the Causal Link.

La Clinica terapeutica·2026
Same journal

The therapeutic potential of N-acetylcysteine across multiple organ systems: a narrative review.

La Clinica terapeutica·2026
Same journal

Mesotherapy in Pain Management in Primary Care: A Narrative Review and Practice-Oriented Appraisal.

La Clinica terapeutica·2026
Same journal

Bone Marrow Edema in Rheumatic Diseases: Incidence, Diagnosis, and Therapeutic Implications. A Narrative Review.

La Clinica terapeutica·2026
See all related articles

Nizatidine, an H2-antagonist, shows comparable efficacy to other treatments for duodenal ulcers. This study found nizatidine had fewer side effects than ranitidine in randomized clinical trials.

Area of Science:

  • Gastroenterology
  • Pharmacology
  • Clinical Medicine

Background:

  • Duodenal ulcer disease is a common gastrointestinal condition.
  • H2-antagonists are a primary treatment for duodenal ulcers.
  • Nizatidine is a potent H2-antagonist with a known safety profile.

Purpose of the Study:

  • To evaluate the therapeutic efficacy and safety of Nizatidine compared to other treatments for duodenal ulcer disease.
  • To assess Nizatidine's effectiveness in both acute and long-term treatment of duodenal ulcers.
  • To compare side effect profiles of Nizatidine versus Ranitidine.

Main Methods:

  • A systematic search of randomized clinical trials published between 1986 and 1992 was conducted using the MEDLINE database.
  • Meta-analysis was employed to compare the efficacy and safety of Nizatidine against other H2-antagonists and placebo.

Related Experiment Videos

  • Data from trials focusing on acute and long-term duodenal ulcer treatment were analyzed.

    • Main Results:

    • Nizatidine demonstrated therapeutic efficacy comparable to other H2-antagonists.
    • Meta-analysis revealed no significant differences in efficacy between Nizatidine and Ranitidine for duodenal ulcer treatment.
    • Nizatidine was associated with a lower incidence of adverse side effects compared to Ranitidine.

    Conclusions:

    • Nizatidine is an effective treatment option for duodenal ulcer disease, with efficacy similar to other H2-antagonists.
    • Nizatidine offers a favorable safety profile, exhibiting fewer side effects than Ranitidine.
    • The findings support Nizatidine's use in the management of duodenal ulcers.